7th MIM Pan African Malaria conference report

In a viral haemorrhagic disease where up to 40% of people developing it die, it is remarkable that doctors still do not agree whether the only recognised treatment, an antiviral drug called ribavirin, makes a difference. In a new Cochrane Review a team of authors at LSTM, along with colleagues in London, The Philippines and in Greece, evaluated the evidence to assess the effectiveness of treating Crimean Congo haemorrhagic fever (CCHF).

Leslie ChoiResearch AssistantLeslie.Choi@lstmed.ac.uk

Dr Rachael MilliganClinical Research FellowRachael.Milligan@lstmed.ac.uk

Details below on the latest submission to the Cochrane Database of Systematic Reviews Issue 5, 2018 from the Cochrane Infectious Diseases Group (reviews and protocols published 1 - 31 May ).Updated Review

Dr Paul Hine Research Assistant Paul.Hine@lstmed.ac.uk

Oman is the oldest independent state in the Arab world and is currently hosting just over 190,000 refugees from the current conflict in Yemen.

Dr Samuel Johnson Research AssociateSamuel.Johnson@lstmed.ac.uk

Dr Harriet BlundellClinical Research Associate 

Details below on the latest submission to the Cochrane Database of Systematic Reviews Issue 4, 2018 from the Cochrane Infectious Diseases Group (reviews and protocols published 1 - 30 April ).Reviews